Nicholas Stollenwerk, M.D.
Critical Care Medicine
- Associate Clinical Professor, Internal Medicine-Pulmonary and Critical Care Medicine
- Medical Director, Pulmonary Services Laboratory
- Associate Program Director, Pulmonary and Critical Care Fellowship Program
- Course Instructor of Record, Medical Student Pulmonary Pathophysiology
UC Davis Medical Group - Sacramento (J Street)
2825 J St., Suite 400
Sacramento, CA 95816
UC Davis Comprehensive Cancer Center
2279 45th Street
Sacramento, CA 95817
Philosophy of Care
Patients want high quality medical care, and they want it provided in an efficient and timely manner. They also want a health care provider that values communication; one that communicates with clarity and compassion. I share these beliefs. It is my goal to provide care that reflects these values.
Dr. Stollenwerk's clinical interests:
- Interventional Pulmonology: advanced diagnostic bronchoscopy, airway interventions, and pleural disease management
- Lung cancer: diagnosis, staging, and management
- Cystic fibrosis
Critical Care Medicine:
- Medical critical care
- Multidisciplinary care for critically ill subspecialty patients
- Bedside ICU procedures for the diagnosis and management of critical illness
Independent of the specific disease being managed, I am interested in the application of ultrasound performed by the clinician at the time of direct patient care. This application of point-of-care ultrasound can improve the safety of medical procedures, improve diagnostic accuracy, and help direct patient management and further diagnostic testing.
As a clinician-educator, my academic interests focus on bedside teaching, as well as course and curriculum development.
Specifically, I am interested in the following:
- Developmental learning theory for training future physicians: I am primarily interested in teaching learners the skills they need to become better future clinicians. However, I am particularly interested in teaching students, and young physicians, how to become better leaders and teachers themselves. It is also my goal for learners to develop the skills necessary to continue to learn after they finish training.
- Teaching procedures: In additional to teaching basic and advanced procedures, I focus on improving procedure safety and teaching less invasive procedural approaches.
- Expanding the application of point-of-care ultrasound: I am interested in expanding use in both in the inpatient and outpatient clinical setting, and for diagnosis and for therapeutic procedures.
M.D., UCLA School of Medicine, Los Angeles CA 2001
B.S., UC Riverside, Riverside CA 1998
University of California Harbor-UCLA Medical Center, Torrance CA 2001-2005
UC Davis Medical Center, Sacramento CA 2005-2008
American Board of Internal Medicine, Pulmonary Medicine, 2008
American Association for Bronchology and Interventional Pulmonology
American College of Chest Physicians
American Thoracic Society
Association of Pulmonary and Critical Care Program Directors
International Association for the Study of Lung Cancer
Honors and Awards
Magna Cum Laude, BS, UCR/UCLA Biomedical Sciences Program, 1998
UC Davis Department of Internal Medicine, Fellow of the Year 2006, 2007
Select Recent Publications
Sandrock C, Stollenwerk N. Acute febrile respiratory illness in the ICU: reducing disease transmission. Chest, 133(5): 1221-31, 2008.
Stollenwerk N, Harper RW, Sandrock CE. Bench-to-bedside review: rare and common viral infections in the intensive care unit--linking pathophysiology to clinical presentation. Crit Care, 12(4): 219, 2008.
Stollenwerk, N.S. and R.S. Tharratt. Asthma: Should you try a new approach? Cortlandt Forum, 39-40, 2007.
Stollenwerk, N.S. and R.S. Tharratt. Asthma: Should you try a new approach? The Clinical Advisor, 38-41, 2007.
Bhalla V, Nast CC, Stollenwerk N, Tran S, Barba L, Kamil ES, Danovitch G, Adler SG. Recurrent and de novo diabetic nephropathy in renal allografts. Transplantation, 75(1): 66-71, 2003.
Marten NW, Hsiang CH, Yu L, Stollenwerk NS, Straus DS. Functional activity of hepatocyte nuclear factor-1 is specifically decreased in amino acid-limited hepatoma cells. Biochim Biophys Acta, 1447(2-3): 160-74, 1999.